Reactive Oxygen Species Can Provide Atheroprotection via NOX4-Dependent Inhibition of Inflammation and Vascular Remodeling
Stephen P Gray, Elyse Di Marco, Kit Kennedy, Phyllis Chew, Jun Okabe, Assam El-Osta, Anna C Calkin, Erik AL Biessen, Rhian M Touyz, Mark E Cooper, Harald HHW Schmidt, Karin AM Jandeleit-Dahm
Arteriosclerosis, Thrombosis, and Vascular Biology | LIPPINCOTT WILLIAMS & WILKINS | Published : 2016
Awarded by EU (ERC)
Awarded by British Heart Foundation
This work was supported by the National Health and Medical Research Council (NHMRC) project grant of Australia, the Juvenile Diabetes Research Foundation, and the Diabetes Australia Research Trust. K.A.M. Jandeleit-Dahm is supported by a NHMRC Senior Research Fellowship and M.E. Cooper is supported by an NHMRC Senior Principal Research Fellowship. S.P. Gray is supported by the Australian Diabetes Society Skip Martin Early Career Fellowship. E. Di Marco is supported by the National Heart Foundation Postgraduate Scholarship. A.C. Calkin is supported by a National Heart Foundation Future Leader Fellowship. H.H.H.W. Schmidt is supported by the EU (Marie Curie International Reintegration Grant and the ERC Advanced Grant 30983347E RADMED) and a cofounder and minor shareholder of Vasopharm GmbH, Wurzburg, Germany. This study was also supported, in part, by the Victorian Government's Operational Infrastructure Support Program.